Corrigendum to: Pharmacokinetic-Pharmacodynamic Model of Vedolizumab for Targeting Endoscopic Remission in Patients with Crohn Disease: Posthoc Analysis of the LOVE-CD Study.

Hanzel, Jurij; Dreesen, Erwin; Vermeire, Séverine; Löwenberg, Mark; Hoentjen, Frank; Bossuyt, Peter; Clasquin, Esmé; Baert, Filip J; D'Haens, Geert R; Mathôt, Ron

Hanzel, Jurij; Dreesen, Erwin; Vermeire, Séverine; Löwenberg, Mark; Hoentjen, Frank; Bossuyt, Peter; Clasquin, Esmé; Baert, Filip J; D'Haens, Geert R; Mathôt, Ron.

Afiliación

Hanzel J; Faculty of Medicine, University of Ljubljana, University Medical Centre Ljubljana, Ljubljana, Slovenia.
Dreesen E; Department of Gastroenterology and Hepatology, Amsterdam UMC, Amsterdam, the Netherlands.
Vermeire S; Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
Löwenberg M; Department of Pharmacy, Uppsala University, Uppsala, Sweden.
Hoentjen F; Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium.
Bossuyt P; Department of Gastroenterology and Hepatology, Amsterdam UMC, Amsterdam, the Netherlands.
Clasquin E; Department of Gastroenterology and Hepatology, Radboud UMC, Nijmegen, the Netherlands.
Baert FJ; Imelda GI Clinical Research Centre, Imelda General Hospital, Bonheiden, Belgium.
D'Haens GR; Department of Gastroenterology and Hepatology, Amsterdam UMC, Amsterdam, the Netherlands.
Mathôt R; Division of Gastroenterology, AZ Delta, Roeselare, Belgium.

Inflamm Bowel Dis ; 28(5): 817, 2022 May 04.

Article en En | MEDLINE | ID: mdl-34788812

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Inflamm Bowel Dis Asunto de la revista: GASTROENTEROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Eslovenia Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google